checkAd
    Startseite > Aktien > Kura Oncology > Nachrichten
    Kura Oncology Aktie
    18,750
     
    USD
    +0,11 %
    +0,020 USD
    Letzter Kurs 02:00:00 Nasdaq
    18,760
     
    USD
    300 STK
    Geldkurs 24.04.24
    18,770
     
    USD
    500 STK
    Briefkurs 24.04.24
    ISIN: US50127T1097 · WKN: A143UH · SYM: KURA · USA

    Neueste Nachrichten

    Kura Oncology Receives Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AML
    22.04.24 · globenewswire · Kura Oncology
    Kura Oncology to Participate in Stifel Targeted Oncology Forum
    10.04.24 · globenewswire · Kura Oncology
    Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    05.04.24 · globenewswire · Kura Oncology
    Kura Oncology Reports First Patient Dosed in Trial of KO-2806 Plus Cabozantinib in Renal Cell Carcinoma
    06.03.24 · globenewswire · Kura Oncology
    Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    01.03.24 · globenewswire · Kura Oncology
    Kura Oncology Reports Fourth Quarter and Full Year 2023 Financial Results
    27.02.24 · globenewswire · Kura Oncology
    Kura Oncology Doses First Patient in KOMET-008 Trial of Ziftomenib in Combination with Standards of Care, Including FLT3 Inhibitor, in Acute Myeloid Leukemia
    26.02.24 · globenewswire · Kura Oncology
    Kura Oncology to Participate in Three Upcoming Investor Conferences
    22.02.24 · globenewswire · Kura Oncology
    Kura Oncology to Report Fourth Quarter and Full Year 2023 Financial Results
    20.02.24 · globenewswire · Kura Oncology
    Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    02.02.24 · globenewswire · Kura Oncology
    Kura Oncology Reports Positive Preliminary Ziftomenib Combination Data in Acute Myeloid Leukemia
    30.01.24 · globenewswire · Kura Oncology
    Kura Oncology Announces Oversubscribed $150 Million Private Placement
    24.01.24 · globenewswire · Kura Oncology